Cargando…

Effect of an Experimental Formulation Containing Chlorhexidine on Pathogenic Biofilms and Drug Release Behavior in the Presence or Absence of Bacteria

(1) Background: For any antibacterial oral formulation to be successful, it must present effects in the presence of biofilms. Therefore, our aim is to analyze the drug release and the antibiofilm effects of a semi-solid formulation containing chlorhexidine (CHX) in the presence of pathogenic biofilm...

Descripción completa

Detalles Bibliográficos
Autores principales: Ré, Ana Carolina S., Bonjovanni, Maria Carolina, Ferreira, Maíra P., Freitas, Osvaldo, Aires, Carolina P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410057/
https://www.ncbi.nlm.nih.gov/pubmed/30791400
http://dx.doi.org/10.3390/pharmaceutics11020088
_version_ 1783402144556122112
author Ré, Ana Carolina S.
Bonjovanni, Maria Carolina
Ferreira, Maíra P.
Freitas, Osvaldo
Aires, Carolina P.
author_facet Ré, Ana Carolina S.
Bonjovanni, Maria Carolina
Ferreira, Maíra P.
Freitas, Osvaldo
Aires, Carolina P.
author_sort Ré, Ana Carolina S.
collection PubMed
description (1) Background: For any antibacterial oral formulation to be successful, it must present effects in the presence of biofilms. Therefore, our aim is to analyze the drug release and the antibiofilm effects of a semi-solid formulation containing chlorhexidine (CHX) in the presence of pathogenic biofilms. (2) Methods: The biofilms of Streptococcus mutans (n = 6) or Porphyromonas gingivalis (n = 3) were formed for 6 and 4 days, respectively, being exposed to: 1) a CHX system or 2) vehicle control without CHX. A group without treatment was included as negative control. The acidogenicity, CHX quantification and bacterial viability were determined. A dissolution assay in a buffer and culture medium in the absence of bacteria was also performed. (3) Results: Although the CHX quantification in the culture medium of both biofilms was lower compared to the buffer (p < 0.05) and the culture medium in the absence of bacteria, the CHX system was able to display antibiofilm effects until 96 h for the S. mutans biofilms (p < 0.05) and 72 h for the P. gingivalis biofilms (p < 0.05). (4) Conclusions: The experimental formulation is able to extend chlorhexidine effects, even in challenging conditions such as in the presence of bacteria, allowing the in vitro control of cariogenic biofilms for 4 days and periodontopathogenic biofilms for 3 days.
format Online
Article
Text
id pubmed-6410057
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64100572019-03-29 Effect of an Experimental Formulation Containing Chlorhexidine on Pathogenic Biofilms and Drug Release Behavior in the Presence or Absence of Bacteria Ré, Ana Carolina S. Bonjovanni, Maria Carolina Ferreira, Maíra P. Freitas, Osvaldo Aires, Carolina P. Pharmaceutics Article (1) Background: For any antibacterial oral formulation to be successful, it must present effects in the presence of biofilms. Therefore, our aim is to analyze the drug release and the antibiofilm effects of a semi-solid formulation containing chlorhexidine (CHX) in the presence of pathogenic biofilms. (2) Methods: The biofilms of Streptococcus mutans (n = 6) or Porphyromonas gingivalis (n = 3) were formed for 6 and 4 days, respectively, being exposed to: 1) a CHX system or 2) vehicle control without CHX. A group without treatment was included as negative control. The acidogenicity, CHX quantification and bacterial viability were determined. A dissolution assay in a buffer and culture medium in the absence of bacteria was also performed. (3) Results: Although the CHX quantification in the culture medium of both biofilms was lower compared to the buffer (p < 0.05) and the culture medium in the absence of bacteria, the CHX system was able to display antibiofilm effects until 96 h for the S. mutans biofilms (p < 0.05) and 72 h for the P. gingivalis biofilms (p < 0.05). (4) Conclusions: The experimental formulation is able to extend chlorhexidine effects, even in challenging conditions such as in the presence of bacteria, allowing the in vitro control of cariogenic biofilms for 4 days and periodontopathogenic biofilms for 3 days. MDPI 2019-02-19 /pmc/articles/PMC6410057/ /pubmed/30791400 http://dx.doi.org/10.3390/pharmaceutics11020088 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ré, Ana Carolina S.
Bonjovanni, Maria Carolina
Ferreira, Maíra P.
Freitas, Osvaldo
Aires, Carolina P.
Effect of an Experimental Formulation Containing Chlorhexidine on Pathogenic Biofilms and Drug Release Behavior in the Presence or Absence of Bacteria
title Effect of an Experimental Formulation Containing Chlorhexidine on Pathogenic Biofilms and Drug Release Behavior in the Presence or Absence of Bacteria
title_full Effect of an Experimental Formulation Containing Chlorhexidine on Pathogenic Biofilms and Drug Release Behavior in the Presence or Absence of Bacteria
title_fullStr Effect of an Experimental Formulation Containing Chlorhexidine on Pathogenic Biofilms and Drug Release Behavior in the Presence or Absence of Bacteria
title_full_unstemmed Effect of an Experimental Formulation Containing Chlorhexidine on Pathogenic Biofilms and Drug Release Behavior in the Presence or Absence of Bacteria
title_short Effect of an Experimental Formulation Containing Chlorhexidine on Pathogenic Biofilms and Drug Release Behavior in the Presence or Absence of Bacteria
title_sort effect of an experimental formulation containing chlorhexidine on pathogenic biofilms and drug release behavior in the presence or absence of bacteria
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410057/
https://www.ncbi.nlm.nih.gov/pubmed/30791400
http://dx.doi.org/10.3390/pharmaceutics11020088
work_keys_str_mv AT reanacarolinas effectofanexperimentalformulationcontainingchlorhexidineonpathogenicbiofilmsanddrugreleasebehaviorinthepresenceorabsenceofbacteria
AT bonjovannimariacarolina effectofanexperimentalformulationcontainingchlorhexidineonpathogenicbiofilmsanddrugreleasebehaviorinthepresenceorabsenceofbacteria
AT ferreiramairap effectofanexperimentalformulationcontainingchlorhexidineonpathogenicbiofilmsanddrugreleasebehaviorinthepresenceorabsenceofbacteria
AT freitasosvaldo effectofanexperimentalformulationcontainingchlorhexidineonpathogenicbiofilmsanddrugreleasebehaviorinthepresenceorabsenceofbacteria
AT airescarolinap effectofanexperimentalformulationcontainingchlorhexidineonpathogenicbiofilmsanddrugreleasebehaviorinthepresenceorabsenceofbacteria